Karen Price
About Karen Price
Karen Price is the Scientific Director and Neuroscience Therapeutic Area Head at Bristol-Myers Squibb, with extensive experience in regulatory toxicology, immunotoxicology, and neuroscience.
Current Position at Bristol-Myers Squibb
Karen Price currently serves as the Scientific Director and Neuroscience Therapeutic Area Head at Bristol-Myers Squibb. In this role, she oversees scientific research and strategy within the Neuroscience Therapeutic Area, leveraging her extensive background in regulatory toxicology, immunotoxicology, and drug development.
Previous Roles at Bristol-Myers Squibb
Karen Price has held several positions at Bristol-Myers Squibb over a noteworthy tenure starting in 1996. Her roles have included Senior Principal Scientist and Principal Scientist from 2010 to 2020, Group Leader from 2005 to 2010, Manager from 2002 to 2005, and Research Investigator and Senior Research Investigator from 1996 to 2002. Her successive roles have provided her with comprehensive experience in scientific leadership and drug safety.
Educational Background in Biotechnology and Immunology
Karen Price holds a Master's degree in Immunology - Cell and Molecular Biology from the State University of New York Upstate Medical University, completed between 1993 and 1995. She also earned a Bachelor of Science degree in Biotechnology from the Rochester Institute of Technology, where she studied from 1989 to 1993. Her academic background laid a strong foundation for her subsequent contributions to the fields of immunotoxicology and drug development.
Experience in Drug Safety and Development
Karen Price has extensive experience in regulatory toxicology and has been a project manager for various drug safety initiatives. Her work spans all phases of drug development, with a particular focus on the interface between immunotoxicology, biologics, small molecules, immunooncology, and immunotherapy. She has successfully navigated complex drug safety projects, collaborating closely with global health authorities.
Expertise in Neuroscience and Nonclinical Safety
In her capacity as Neuroscience Therapeutic Area Head, Karen Price brings a deep understanding of neuroscience, particularly in the context of nonclinical safety. Her role involves guiding research and safety assessments essential for advancing therapeutic innovations in neuroscience. Her expertise ensures that the therapeutic candidates meet stringent safety standards before advancing to clinical stages.